UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
LBPH holding history
Longboard Pharmaceuticals, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LBPH overviewAll 13F holders of LBPHFull Q4 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −39,260−100.0% | Sold out | Holders |
| Q3 2024 | 39,260 | $1.31M | <0.1% | −12,336−23.9% | Reduced | Holders |
| Q2 2024 | 51,596 | $1.39M | <0.1% | −2,457−4.5% | Reduced | Holders |
| Q1 2024 | 54,053 | $1.17M | <0.1% | −69,153−56.1% | Reduced | Holders |
| Q4 2023 | 123,206 | $742.9K | <0.1% | −139,059−53.0% | Reduced | Holders |
| Q3 2023 | 262,265 | $1.46M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 262,265 | $1.93M | <0.1% | +32,265+14.0% | Added | Holders |
| Q1 2023 | 230,000 | $903.9K | <0.1% | +230,000 | New | Holders |